All ProductsDisplaying Products by Catalog Number (6700 - 6799)
01000200030004000500060007000800090010001100120013001400150016001700180019002000210022002300240025002600270028002900300031003200330034003500360037003800390040004100420043004400450046004700480049005000510052005300540055005600570058005900600061006200630064006500660067006800690070007100720073007400750076007700780079008000810082008300840085008600870088008900
| Cat. No. | Product Name / Activity |
|---|---|
| 6701 | 1A-116 |
| Rac1 inhibitor; blocks Rac1-P-Rex1 interaction | |
| 6703 | BGP 15 |
| PARP inhibitor; cytoprotectant | |
| 6709 | GSK 2018682 |
| S1P1 and S1P5 agonist | |
| 6710 | Darunavir |
| Highly potent HIV protease inhibitor | |
| 6715 | A 71915 |
| Highly potent and competitive NPRA antagonist | |
| 6716 | Pomalidomide 4'-alkylC5-amine |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
| 6717 | FFN 270 |
| Fluorescent substrate for NET and VMAT2 | |
| 6718 | ±-MF 094 |
| Selective USP30 inhibitor | |
| 6724 | CBA |
| Selective TRPM4 blocker | |
| 6725 | CHDI 00390576 |
| Potent and selective class IIa HDAC inhibitor; brain penetrant | |
| 6728 | RGFP 966 |
| Potent and selective HDAC3 inhibitor | |
| 6738 | KT 182 |
| Potent, selective and irreversible α/β-hydrolase domain 6 (ABHD6) inhibitor | |
| 6739 | YNT 185 |
| Potent and selective OX2 agonist | |
| 6741 | GW 4869 |
| Selective neutral sphingomyelin phosphodiesterase (N-SMase) inhibitor | |
| 6742 | Acetazolamide |
| Carbonic anhydrase inhibitor | |
| 6744 | TL 13-12 |
| Selective ALK Degrader (PROTAC®) | |
| 6745 | TL 13-112 |
| Selective ALK Degrader (PROTAC®) | |
| 6746 | TL 13-110 |
| Negative control for TL 13-112 (Cat. No. 6745) | |
| 6747 | TL 13-22 |
| Negative control for TL 13-12 (Cat. No. 6744) | |
| 6748 | PRX 07034 |
| Potent and selective 5-HT6 antagonist | |
| 6751 | (R)-(-)-Ketamine hydrochloride |
| NMDA antagonist; antidepressant; may not display psychotomimetic or addictive side effects of (S)-ketamine | |
| 6753 | CHS 828 |
| NAMPT inhibitor; active in vivo and cytotoxic | |
| 6754 | LJI308 |
| Potent pan-RSK inhibitor | |
| 6755 | Darapladib |
| Potent lp-PLA2 inhibitor | |
| 6757 | t-TUCB |
| Potent soluble epoxide hydrolase (sEH) Inhibitor; anti-inflammatory and antinociceptive | |
| 6758 | CLP 290 |
| K+/Cl- cotransporter 2 (KCC2) activator; orally bioavailable prodrug of CLP 257 (Cat. No.5242) | |
| 6759 | AA 147 |
| ER proteostasis regulator | |
| 6762 | Urolithin A |
| PI 3-K/Akt/mTOR signaling inhibitor; blocks phosphorylation of Akt and p70S6K in vitro | |
| 6764 | B 973B |
| Positive allosteric modulator of α7 nAChRs; analgesic | |
| 6766 | AC 1903 |
| Selective TRPC5 inhibitor | |
| 6770 | ABT 639 |
| CaV3.2 and CaV3.1 channel blocker; orally bioavailable | |
| 6774 | 16673-34-0 NLRP3i |
| NLRP3 inflammasome inhibitor | |
| 6775 | ST 045849 |
| O-GlcNAc transferase (OGT) inhibitor | |
| 6777 | TAK 375 |
| Very high affinity and selective melatonin receptor agonist | |
| 6779 | Davunetide |
| Highly potent active component of ADNP; prevents amyloid β aggregation; active in vivo | |
| 6781 | Capzimin dimer |
| Selective proteasome inhibitor | |
| 6782 | Indisulam |
| Molecular glue; pre-mRNA splicing modulator | |
| 6784 | FTBMT |
| Potent and selective GPR52 agonist; orally bioavailable and BBB permeable | |
| 6785 | E 7820 |
| α2 integrin inhibitor; anti-angiogenic | |
| 6788 | Quizartinib |
| Highly potent FLT3 inhibitor | |
| 6789 | K 03861 |
| Potent CDK2 inhibitor | |
| 6790 | GSK 126 |
| Very high affinity and selective EZH2 inhibitor | |
| 6791 | BC-LI-0186 |
| Leucyl-tRNA synthase (TRS)/Ras-related GTP-binding protein D (RagD) interaction inhibitor | |
| 6792 | Omipalisib |
| Highly potent PI 3-kinase inhibitor; also potent inhibitor of mTOR and DNA-PK | |
| 6793 | Dasatinib |
| Highly potent pan-Src/Bcr-Abl inhibitor | |
| 6795 | GeA-69 |
| Selective allosteric PARP14 inhibitor | |
| 6798 | Click N-Acetylmuramic acid - alkyne |
| Bacterial peptidoglycan derivative; suitable for 'click'-conjugation to fluorescent dyes |